etoposide has been researched along with lactoferrin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Kuo, YC | 1 |
| Alexander, J; Coupland, SE; Jana, P; Kaliki, S; Kalirai, H; Kondapi, AK; Manukonda, R; Nair, RM; Narayana, RVL; Prabhu, V; Tomar, N; Vemuganti, GK | 1 |
| Angulo-Zamudio, UA; Arredondo-Beltrán, IG; Bolscher, JGM; Canizalez-Roman, A; León-Sicairos, N; Nazmi, K; Ramírez-Sánchez, DA; Velazquez-Roman, JA; Zazueta-García, JR | 1 |
3 other study(ies) available for etoposide and lactoferrin
| Article | Year |
|---|---|
Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
Topics: Antineoplastic Agents, Phytogenic; Astrocytes; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cells, Cultured; Drug Delivery Systems; Endothelial Cells; Etoposide; Folate Receptors, GPI-Anchored; Folic Acid; Glioblastoma; Humans; Lactic Acid; Lactoferrin; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Receptors, Cell Surface; Topoisomerase II Inhibitors | 2015 |
Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biological Availability; Carboplatin; Chromatography, High Pressure Liquid; Culture Media; Drug Carriers; Drug Delivery Systems; Etoposide; Flow Cytometry; Humans; Lactoferrin; Microscopy, Confocal; Microscopy, Electron, Transmission; Nanoparticles; Neoplastic Stem Cells; Retinal Neoplasms; Retinoblastoma; Spectroscopy, Fourier Transform Infrared | 2021 |
Antitumor activity of bovine lactoferrin and its derived peptides against HepG2 liver cancer cells and Jurkat leukemia cells.
Topics: Child; Cisplatin; Etoposide; Hep G2 Cells; Humans; Jurkat Cells; Lactoferrin; Liver Neoplasms; Necrosis; Peptides; Quality of Life | 2023 |